Company
DenmarkPublic company, NYSE: NVONovo Nordisk A/S (NYSE: NVO), Kalundborg, Denmark – FDA Inspections
Inspection records and compliance data for Novo Nordisk A/S in Kalundborg. 11 FDA inspections on record, 2 Form 483s, last inspected March 25, 2024. Publicly traded as NYSE: NVO.
Company Profile
This profile covers Novo Nordisk A/S based in Kalundborg, Denmark.
FDA Inspection History
- FDA inspections
- 11
- OAI
- 0
- VAI
- 6
- NAI
- 3
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected February 24, 2009. Last inspected March 25, 2024.
FDA inspections (11)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 25, 2024 | Not classified | Human Drugs | 1269488 |
| May 4, 2023 | VAI | Biologics · Blood and Blood Products | 1209127 |
| December 2, 2022 | VAI | Human Drugs · Drug Quality Assurance | 1230597 |
| September 6, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1107225 |
| March 7, 2018 | Not classified | Biologics | 1044502 |
| August 29, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1028554 |
| March 7, 2014 | NAI | Human Drugs · Drug Quality Assurance | 872670 |
| May 10, 2013 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 861829 |
| March 9, 2012 | VAI | Human Drugs · Drug Quality Assurance | 777396 |
| February 8, 2011 | VAI | Biologics · Blood and Blood Products | 730949 |
| February 24, 2009 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 574834 |
FDA documents
Form 483s (2)
EIRs (1)
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novo Nordisk A/S
Stock ticker
NVO
Exchange
NYSE
Share price
$40.66
Market cap
$180.0B
Price as of
November 13, 2026
FEI Number
3002807751
Address
Hallas Alle 1, Kalundborg, Denmark
Country
Denmark
ID: b48359f1-0bb7-4fff-80dd-688aab40951b